• EOFLOW closes two back-to-back rounds of funding

  • EOFLOW announces the closing of its Series-C and C+ rounds of funding.  Through this unusual back-to-back funding rounds with two different valuations (with the C+ being higher than the C-round that closed unannounced a month earlier), the company has raised a total of 14Billion KRW (about $14M) from four investors, of which two are existing shareholders of EOFLOW.   With the latest rounds of funding, combined with the recent award from JDRF (Juvenile Diabetes Research Foundation) and some fresh government grants, EOFLOW is well positioned to build inroads for the first commercial product, EOPatch, in Korea, as well as for the execution of follow-on product development/launch plans.

We use cookies. By continuing to use our site you accept our cookie policy. Find out more about our privacy policy here